le site du cnr des mycobactéries CHANGE D’ADRESSE

NOUVELLE ADRESSE : aller à --->> https://cnrmyrma.fr/

Accueil du site > CNR > Les publications du CNR > Publications du CNR en 2006
  • Article

  Publications du CNR en 2006

dimanche 13 janvier 2008

2011 / 2010 / 2009 / 2008 / 2007 / 2006 / 2005 / 2004 / 2003


- F. Brossier, Veziris N, Truffot-Pernot C, Jarlier V, Sougakoff W. Performance of the genotype MTBDR line probe assay for detection of resistance to rifampin and isoniazid in strains of Mycobacterium tuberculosis with low- and high-level resistance. J Clin Microbiol. 2006 ;44(10):3659-64.

- E. Guerrin-Tran, J-M. Thiolet, C. Rousseau, S. Henry, C. Poirier, D. Che, J-M. Vinas, V. Jarlier, J. Robert and the AZAY-MYCOBACTERIA network. An evaluation of data quality in a network for surveillance of Mycobacterium tuberculosis resistance to antituberculosis drugs in Ile-de-France region-2001-2002. Eur J Epidemiol. 2006 ;21(10):783-785

- Lounis N, Veziris N, Chauffour A, Truffot-Pernot C, Andries K, Jarlier V. Combinations of r207910 with drugs used to treat multidrug-resistant tuberculosis have the potential to shorten treatment duration.Antimicrob Agents Chemother. 2006 ;50(11):3543-7.

- E. Cambau, L. Carthagena, A. Chauffour, B. Ji, V. Jarlier. Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy. Clin Infect Dis. 2006 ; 42 :238-241.

- B. Ji, A. Chauffour, K. Andries, V. Jarlier. Bactericidal Activities of R207910 and Other Newer Antimicrobial Agents against Mycobacterium leprae in Mice. Antimicob. Agents Chemother 2006 ; 50:1558-1560.

- Levy L, Ji B. The mouse foot-pad technique for cultivation of Mycobacterium leprae. Lepr Rev. 2006 Mar ;77:5-24.

- A. Aubry, N. Veziris, E. Cambau, C. Truffot-Pernot, V. Jarlier, L.M. Fisher. Novel gyrase mutations in Quinolone-resistant and –hypersusceptible clinical isolates of M. tuberculosis : functional analysis of mutant enzymes. Antimicrob. Agents Chemother. 2006 ; 50:104-112.

- Aubry A, Fisher Ml, Jarlier V, Cambau E. First functional characterization of a singly expressed bacterial type II topoisomerase : The enzyme from Mycobacterium tuberculosis. Biochem Biophys Res Commun. 2006 ;348:158-165.

- Petrella S, Cambau E, Chauffour A, Andries K, Jarlier V, Sougakoff W. Genetic basis for natural and acquired resistance to the diarylquinoline r207910 in mycobacteria. Antimicrob Agents Chemother. 2006 ;50:2853-6.

- Chai N, Deforges L, Sougakoff W, Truffot-Pernot C, De Luze A, Demeneix B, Clement M, Bomsel Mc. Mycobacterium szulgai infection in a captive population of african clawed frogs (Xenopus tropicalis). Journal of Zoo and Wildlife Medicine 2006 ;37:55-58.

- B. Ji, S. Lefrançois, J. Robert, A. Chauffour, C. Truffot-Pernot, V. Jarlier. In vitro and in vivo activities of rifampicin, streptomycin, amikacin, moxifloxacin, R207910, linezolid and PA-824 against Mycobacterium ulcerans. Antimicrob Agents Chemother 2006 ; 50:1921-1926.

- E. Guerrin-Tran, J-M. Thiolet, C. Rousseau, S. Henry, C. Poirier, D. Che, J-M. Vinas, V. Jarlier, J. Robert et le réseau AZAY-MYCOBACTERIES. Evaluation de la qualité d’un réseau de surveillance de la tuberculose résistante en Ile-de-France en 2001-2002 (réseau Azay-Mycobactéries). Bulletin Epidemiologique Hebdomadaire 2006 (13):90-93.

- Pulcini C, E. Vandenbussche, I. Podglajen, W. Sougakoff, C. Truffot-Pernot, A. Buu-Hoi, E. Varon, Jl Mainardi. Hip prosthesis infection due to Mycobacterium wolinskyi. J Clin Microbiol. 44(9) : 3463-3464.

- Anquetin G, Greiner J, Mahmoudi N, Santillana-Hayat M, Gozalbes R, Farhati K, Derouin F, Aubry A, Cambau E, Vierling P. Design, synthesis and activity against Toxoplasma gondii, Plasmodium spp., and Mycobacterium tuberculosis of new 6-fluoroquinolones. Eur J Med Chem. 2006

- Matrat S, Veziris N, Mayer C, Jarlier V, Truffot-Pernot C, Camuset J, Bouvet E, Cambau E, Aubry A. Functional analysis of DNA gyrase mutant enzymes carrying mutations at position 88 in the A subunit found in clinical strains of Mycobacterium tuberculosis resistant to fluoroquinolones. Antimicrob Agents Chemother. 2006.

- N. Veziris, A. Aubry, J. Robert, E. Cambau, V. Jarlier, C. Truffot-Pernot. Chapitre Mycobactéries, dans « l’Antibiogramme », 2ème édition, Ed ESKA. 2006.

- Argumentation sur la durée des traitements antituberculeux. N. Veziris, A. Aubry, C. Truffot-Pernot. Presse Med. 2006 Nov ;35(11 Pt 2):1758-64.

- Diagnostic moderne de la tuberculose. C. Truffot-Pernot, N. Veziris, W. Sougakoff. Presse Med. 2006 ;35(11 Pt 2):1739-46


2011 / 2010 / 2009 / 2008 / 2007 / 2006 / 2005 / 2004 / 2003